StockTipsArenaBeta

BUY Anthem Biosciences Limited — Prabhudas Lilladher

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1–3 months)9 Jul 2026via Economic Times New Stock Recos

Entry₹748Inferred
Target₹850
Total upside +13.64% (call closed)
Stop lossNot given
Exit₹85010 Aug 2026, 12:08 pm
Target hit+13.64%0.00%upside left
Follow Prabhudas Lilladher for new calls(40% target hit, 10 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Aug 2026
9 supporting4 neutral1 opposing
Supports the BUY call (9)

4 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·6 Aug · 3d ago

Anthem Biosciences Shares Gain 2% After Profit Rises to ₹591 Crore

NewsGoogle News·3 Aug · 6d ago

(opens in new tab)

Anthem Biosciences Share Price: லாபம் **₹591 கோடி** உயர்வு! பங்கு **2%** ஏற்றம்!

NewsGoogle News·3 Aug · 6d ago

(opens in new tab)

Anthem Biosciences शेअरमध्ये तेजी! FY26 मध्ये नफा ₹591 कोटींवर

NewsGoogle News·3 Aug · 6d ago

(opens in new tab)

Anthem Biosciences ਸ਼ੇਅਰਾਂ 'ਚ **2%** ਦਾ ਉਛਾਲ, FY26 'ਚ ਪ੍ਰੋਫਿਟ ਗ੍ਰੋਥ ਦੇ ਸੰਕੇਤ

NewsGoogle News·31 Jul · 1w ago

(opens in new tab)
Neutral / worth noting (4)

Anthem Biosciences Limited has revised its press release regarding the unaudited consolidated financial results for the quarter ended June 30, 2026. The revised release supersedes the previous one.

BSE · Company Update·21 Jul · 3w ago

(opens in new tab)

Anthem Biosciences Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The company reported revenue from operations of ₹4,182 Mn and profit after tax of

BSE · Company Update·21 Jul · 3w ago

(opens in new tab)

Anthem Biosciences Limited announced the outcome of its Board Meeting held on July 21, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 3

BSE · Board Meeting·21 Jul · 3w ago

(opens in new tab)

Anthem Biosciences Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report of the Statut

NSE · Outcome of Board Meeting·21 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

Anthem Biosciences Q1 Results: Shares fall over 7% as delayed deliveries drag earnings

NewsCnbc-Tv18·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Prabhudas Lilladher

Every call and its outcome